136
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Tumor aggressiveness is independent of radiation quality in murine hepatocellular carcinoma and mammary tumor models

, , , , , , , , , , , , , , ORCID Icon, , ORCID Icon, & show all
Pages 1140-1151 | Received 28 Jan 2021, Accepted 03 Mar 2021, Published online: 31 Mar 2021

References

  • Alpen EL, Powers-Risius P, Curtis SB, DeGuzman R. 1993. Tumorigenic potential of high-Z, high-LET charged-particle radiations. Radiat Res. 136(3):382–391.
  • Amr KS, Elmawgoud Atia HA, Elazeem Elbnhawy RA, Ezzat WM. 2017. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma. Genes Dis. 4(4):215–221.
  • Bielefeldt-Ohmann H, Genik PC, Fallgren CM, Ullrich RL, Weil MM. 2012. Animal studies of charged particle-induced carcinogenesis. Health Phys. 103(5):568–576.
  • Chang PY, Cucinotta FA, Bjornstad KA, Bakke J, Rosen CJ, Du N, Fairchild DG, Cacao E, Blakely EA. 2016. Harderian gland tumorigenesis: low-dose and LET response. Radiat Res. 185(5):449–460.
  • Chang Y, Yang Z-Y, Li G-L, Li Q, Yang Q, Fan J-Q, Zhao Y-C, Song Y-Q, Wu G. 2016. Correlations between radiation dose in bone marrow and hematological toxicity in patients with cervical cancer: a comparison of 3DCRT, IMRT, and RapidARC. Int J Gynecol Cancer. 26(4):770–776.
  • Chen T, Dai X, Dai J, Ding C, Zhang Z, Lin Z, Hu J, Lu M, Wang Z, Qi Y, et al. 2020. AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway. Cell Death Dis. 11(10):822.
  • Chen W, Peng J, Ye J, Dai W, Li G, He Y. 2020. Aberrant AFP expression characterizes a subset of hepatocellular carcinoma with distinct gene expression patterns and inferior prognosis. J Cancer. 11(2):403–413.
  • Cucinotta FA, Alp M, Rowedder B, Kim MH. 2015. Safe days in space with acceptable uncertainty from space radiation exposure. Life Sci Space Res (Amst). 5:31–38.
  • Datta K, Suman S, Kallakury BV, Fornace AJ Jr. 2013. Heavy ion radiation exposure triggered higher intestinal tumor frequency and greater β-catenin activation than γ radiation in APC(Min/+) mice. PLoS One. 8(3):e59295.
  • Dicello JF, Christian A, Cucinotta FA, Gridley DS, Kathirithamby R, Mann J, Markham AR, Moyers MF, Novak GR, Piantadosi S, et al. 2004. In vivo mammary tumourigenesis in the Sprague-Dawley rat and microdosimetric correlates. Phys Med Biol. 49(16):3817–3830.
  • Dragani TA, Manenti G, Gariboldi M, De Gregorio L, Pierotti MA. 1995. Genetics of liver tumor susceptibility in mice. Toxicol Lett. 82–83:613–619.
  • Drinkwater NR, Hanigan MH, Kemp CJ. 1989. Genetic determinants of hepatocarcinogenesis in the B6C3F1 mouse. Toxicol Lett. 49(2–3):255–265.
  • Edmondson EF, Gatti DM, Ray FA, Garcia EL, Fallgren CM, Kamstock DA, Weil MM. 2020. Genomic mapping in outbred mice reveals overlap in genetic susceptibility for HZE ion- and γ-ray-induced tumors. Sci Adv. 6(16):eaax5940.
  • Goldberg DS, Fallon MB. 2015. The art and science of diagnosing and treating lung and heart disease secondary to liver disease. Clin Gastroenterol Hepatol. 13(12):2118–2127.
  • Grahn D, Lombard LS, Carnes BA. 1992. The comparative tumorigenic effects of fission neutrons and cobalt-60 gamma rays in the B6CF1 mouse. Radiat Res. 129(1):19–36.
  • Gurakar A, Ma M, Garonzik-Wang J, Kim A, Anders RA, Oshima K, Georgiades C, Gurakar M, Ottmann S, Cameron AM, et al. 2018. Clinicopathological distinction of low-AFP-secreting vs. high-AFP-secreting hepatocellular carcinomas. Ann Hepatol. 17(6):1052–1066.
  • Guy CT, Cardiff RD, Muller WJ. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 12(3):954–961.
  • Hoshida Y, Nijman SMB, Kobayashi M, Chan JA, Brunet J-P, Chiang DY, Villanueva A, Newell P, Ikeda K, Hashimoto M, et al. 2009. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 69(18):7385–7392.
  • Hsu S-H, Wang B, Kota J, Yu J, Costinean S, Kutay H, Yu L, Bai S, La Perle K, Chivukula RR, et al. 2012. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 122(8):2871–2883.
  • Hu J, Wang N, Yang Y, Ma L, Han R, Zhang W, Yan C, Zheng Y, Wang X. 2018. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma. BMC Gastroenterol. 18(1):186.
  • Illa-Bochaca I, Ouyang H, Tang J, Sebastiano C, Mao J-H, Costes SV, Demaria S, Barcellos-Hoff MH. 2014. Densely ionizing radiation acts via the microenvironment to promote aggressive Trp53-null mammary carcinomas. Cancer Res. 74(23):7137–7148.
  • Imaoka T, Nishimura M, Kakinuma S, Hatano Y, Ohmachi Y, Yoshinaga S, Kawano A, Maekawa A, Shimada Y. 2007. High relative biologic effectiveness of carbon ion radiation on induction of rat mammary carcinoma and its lack of H-ras and Tp53 mutations. Int J Radiat Oncol Biol Phys. 69(1):194–203.
  • Ito A, Takahashi T, Watanabe H, Ogundigie PO, Okamoto T. 1992. Significance of strain and sex differences in the development of 252Cf neutron-induced liver tumors in mice. Jpn J Cancer Res. 83(10):1052–1056.
  • John EM, Phipps AI, Knight JA, Milne RL, Dite GS, Hopper JL, Andrulis IL, Southey M, Giles GG, West DW, et al. 2007. Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry. Int J Cancer. 121(2):386–394.
  • Kojima K, Takata A, Vadnais C, Otsuka M, Yoshikawa T, Akanuma M, Kondo Y, Kang YJ, Kishikawa T, Kato N, et al. 2011. MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun. 2:338.
  • Land CE, Tokunaga M, Koyama K, Soda M, Preston DL, Nishimori I, Tokuoka S. 2003. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1990. Radiat Res. 160(6):707–717.
  • Li J, Qiyu S, Wang T, Jin B, Li N. 2019. Improving the detection of hepatocellular carcinoma using serum AFP expression in combination with GPC3 and micro-RNA miR-122 expression. Open Life Sci. 14(1):53–61.
  • Lifsted T, Le Voyer T, Williams M, Muller W, Klein-Szanto A, Buetow KH, Hunter KW. 1998. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer. 77(4):640–644.
  • Liu C, Tanaka K, Katsube T, Varès G, Maruyama K, Ninomiya Y, Fardous Z, Sun C, Fujimori A, Moreno SG, et al. 2020. Altered response to total body irradiation of C57BL/6-Tg (CAG-EGFP) mice. Dose Response. 18(3):1559325820951332.
  • Menezes ME, Das SK, Emdad L, Windle JJ, Wang X-Y, Sarkar D, Fisher PB. 2014. Genetically engineered mice as experimental tools to dissect the critical events in breast cancer. Adv Cancer Res. 121:331–382.
  • Cancer.Net. n.d. [accessed 2021 Mar 19]. https://www.cancer.net.
  • Reliene R, Schiestl RH. 2006. Differences in animal housing facilities and diet may affect study outcomes-a plea for inclusion of such information in publications. DNA Repair (Amst). 5(6):651–653.
  • Sadakane A, Landes RD, Sakata R, Nagano J, Shore RE, Ozasa K. 2019. Medical radiation exposure among atomic bomb survivors: understanding its impact on risk estimates of atomic bomb radiation. Radiat Res. 191(6):507–517.
  • Tai W-C, Hu T-H, Wang J-H, Hung C-H, Lu S-N, Changchien C-S, Lee C-M. 2009. Clinical implications of alpha-fetoprotein in chronic hepatitis C. J Formos Med Assoc. 108(3):210–218.
  • Takahashi T, Watanabe H, Dohi K, Ito A. 1992. 25Cf relative biological effectiveness and inheritable effect of fission neutrons in mouse liver tumorigenesis. Cancer Res. 52(7):1948.
  • Trani D, Datta K, Doiron K, Kallakury B, Fornace AJ Jr. 2010. Enhanced intestinal tumor multiplicity and grade in vivo after HZE exposure: mouse models for space radiation risk estimates. Radiat Environ Biophys. 49(3):389–396.
  • Viotti M, Nowotschin S, Hadjantonakis AK. 2011. Afp::mCherry, a red fluorescent transgenic reporter of the mouse visceral endoderm. Genesis. 49(3):124–133.
  • Wang X, Farris Iii AB, Wang P, Zhang X, Wang H, Wang Y. 2015. Relative effectiveness at 1 gy after acute and fractionated exposures of heavy ions with different linear energy transfer for lung tumorigenesis. Radiat Res. 183(2):233–239.
  • Wang X, Fu X, Van Ness C, Meng Z, Ma X, Huang W. 2013. Bile acid receptors and liver cancer. Curr Pathobiol Rep. 1(1):29–35.
  • Watanabe H, Ogiu T, Nishimura M, Masaoka Y, Kurosumi M, Takahashi T, Oguri T, Shoji S, Katoh O. 1998. Comparison of tumorigenesis between accelerated heavy ion and X-ray in B6C3F1 mice. JRR. 39(2):93–100.
  • Weil MM, Bedford JS, Bielefeldt-Ohmann H, Ray FA, Genik PC, Ehrhart EJ, Fallgren CM, Hailu F, Battaglia CLR, Charles B, et al. 2009. Incidence of acute myeloid leukemia and hepatocellular carcinoma in mice irradiated with 1 GeV/nucleon (56)Fe ions. Radiat Res. 172(2):213–219.
  • Weil MM, Ray FA, Genik PC, Yu Y, McCarthy M, Fallgren CM, Ullrich RL. 2014. Effects of 28Si ions, 56Fe ions, and protons on the induction of murine acute myeloid leukemia and hepatocellular carcinoma. PLoS One. 9(7):e104819.
  • Yim SY, Lee J-S. 2019. The genomic landscape and its clinical implications in hepatocellular carcinoma. J Liver Cancer. 19(2):97–107.
  • Yoshida N, Imada H, Kunugita N, Norimura T. 1993. Low dose radiation-induced adaptive survival response in mouse spleen T-lymphocytes in vivo. J Radiat Res. 34(4):269–276.
  • Zhou Q, Lui VW, Yeo W. 2011. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Future Oncol. 7(10):1149–1167.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.